Tyrogenex
West Palm Beach
About Tyrogenex
Tyrogenex, Inc., a biotechnology company, engages in research and development of multi-kinase angiogenesis inhibitor for the treatment of solid tumors. The company has developed a novel, patented cancer therapeutic, X-82, a dual VEGFR/PDGFR inhibitor. The company was formerly known as Xcovery, Inc. The company was incorporated in 2006 and is based in West Palm Beach, Florida. The company operates as a subsidiary of Xcovery LLC.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $21.4M
- Last round: Series Unknown (Feb 2016)
- Website: tyrogenex.com
- Phone: +1 (855) 978-7025
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tyrogenex-216415 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.